Literature DB >> 32775521

Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's Disease.

Daniel Richter1, Carsten Saft1, Lars Tönges1.   

Abstract

Entities:  

Year:  2020        PMID： 32775521      PMCID： PMC7396839          DOI： 10.1002/mdc3.13002

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  6 in total

1.  Citalopram-induced bruxism.

Authors:  M Wise
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

2.  Bruxism in Huntington's disease.

Authors:  E D Louis; E Tampone
Journal:  Mov Disord       Date:  2001-07       Impact factor: 10.338

3.  Bruxism secondary to chronic antidopaminergic drug exposure.

Authors:  F Micheli; M Fernandez Pardal; M Gatto; J Asconapé; R Giannaula; I C Parera
Journal:  Clin Neuropharmacol       Date:  1993-08       Impact factor: 1.592

Review 4.  Bruxism in Movement Disorders: A Comprehensive Review.

Authors:  Bruno Ella; Imad Ghorayeb; Pierre Burbaud; Dominique Guehl
Journal:  J Prosthodont       Date:  2016-04-14       Impact factor: 2.752

5.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

6.  A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington's Disease.

Authors:  Lars Wojtecki; Stefan J Groiss; Stefano Ferrea; Saskia Elben; Christian J Hartmann; Stephen B Dunnett; Anne Rosser; Carsten Saft; Martin Südmeyer; Christian Ohmann; Alfons Schnitzler; Jan Vesper
Journal:  Front Neurol       Date:  2015-08-18       Impact factor: 4.003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.